Tenor Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Tenor Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-166,666	Closed	-$242K	–	348
2024 Q1	$242K	Hold	166,666	–	–	﹤0.01%	179
2023 Q4	$16.6K	Hold	166,666	–	–	﹤0.01%	216
2023 Q3	$25K	Hold	166,666	–	–	﹤0.01%	218
2023 Q2	$15K	Hold	166,666	–	–	﹤0.01%	259
2023 Q1	$9.17K	Hold	166,666	–	–	﹤0.01%	354
2022 Q4	$7.6K	Hold	166,666	–	–	﹤0.01%	445
2022 Q3	$11K	Hold	166,666	–	–	﹤0.01%	575
2022 Q2	$25K	Hold	166,666	–	–	﹤0.01%	564
2022 Q1	$50K	Hold	166,666	–	–	﹤0.01%	592
2021 Q4	$85K	Hold	166,666	–	–	﹤0.01%	571
2021 Q3	$98K	Hold	166,666	–	–	﹤0.01%	511
2021 Q2	$167K	Buy	+166,666	New	+$126K	﹤0.01%	507

Tenor Capital Management's AEON.WS Position: Q2 2024 in Review

Tenor Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 166,666 shares — an estimated $242K sold.

Tenor Capital Management first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $242K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Tenor Capital Management reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Tenor Capital Management sold 166,666 AEON Biopharma Inc shares in Q2 2024, an estimated $242K.
Tenor Capital Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
Tenor Capital Management's AEON Biopharma Inc position peaked at $242K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Tenor Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.